CARDIFF, CA--(Marketwire - January 20, 2010) -
NI Research, the publisher of NeuroInvestment,
has released the 2010 edition of the Private CNS Company Review. The
completely revised and updated 2010 edition provides a unique database of
information about the private companies specializing in the development of
novel therapeutics for neurological/psychiatric disorders.
For each of the 102 companies covered, PCNS describes and appraises
scientific platforms; clinical/preclinical activity; contact information;
alliances; financing; prospects, and licensing opportunities. Licensing and
M&A opportunities are also compiled and appraised, as are rosters of
company funding and VC financing. NI Research has published PCNS since
2003, and it has become a highly valued Business Development tool for the
neuropharm industry.
Table of Contents for PCNS 2010:
Introduction and Comment
Private Company Fates/Casualties 2003-9
Private CNS Company Funding 2009
Scavenger Hunt
PCNS Licensing Opportunities by Stage
Top PCNS Licensing Opportunities
Top PCNS M&A Opportunities
Accera/Neuera
AC Immune
Acumen Pharmaceuticals
Adamas Pharmaceuticals
Affectis Pharmaceuticals
Affiris
Afraxis
AgeneBio
Alzhyme
American Life Science Pharmaceuticals
Archer Pharmaceuticals
Arcion Therapeutics
ArmaGen Technologies
AurimMed Pharma
Axon-Neuroscience
Axxonis Pharma AG
Azevan Pharmaceuticals
Bayhill Therapeutics
BioArctic Neuroscience
BioChromix Pharma
BrainCells
BrainTact
Cambria Pharmaceuticals
Cara Therapeutics
Cellzome
CeNeRx BioPharma
Ceregene
Clera
Cognition Pharmaceuticals
Cognition Therapeutics
Cognosci
CoLucid
CoMentis
Embera Neurotherapeutics
ENKAM Pharmaceuticals
EnVivo Pharmaceuticals
Galantos Pharma
Galenea
GliaMed
Helicon Therapeutics/
Dart Neuroscience
Intra-Cellular Therapies
KeyNeurotek
Kinexis
Knopp Neurosciences
Link Medicine
Maas Biolab
Medeia Therapeutics
MedGenesis
MediProPharma
Mithridion
M's Science
Neuraltus
NeurAxon
Neureva
Neurim
Neurimmune
NeuroGeneration
NeuroHealing
NeuroKos
Neuronascent
NeuroNova
NeuroProtect
NeuroTherapeutics Pharma
Neurotune AG
NoNO Inc.
Noscira
NsGene
NuPathe
Oligomerix
PharmaNeuroBoost
Pharmaxon
Pharnext
Probiodrug
ProMentis Pharmaceuticals
Proneuron Biotechnologies
Proteostasis Therapeutics
Psyadon Pharmaceuticals
Psylin Neuroscience
Q Therapeutics
RemeGenix
SanBio
Satori Pharmaceuticals
SCT Spinal Cord Therapeutics
Seaside Therapeutics
Senexis
Solace Pharmaceuticals
Solstice Neurosciences
Sonexa Therapeutics
Spinifex
Stealth Peptides
Synosia Therapeutics
TauRx
TauTaTis
TheraQuest Biosciences
to-BBB
Trophos
Xenome Ltd
Yaupon Therapeutics
Zenobia
Zogenix
Programs by Company, Indication, Stage
Company Funding
VC Funding Roster
NI Research is the leading publisher of independent research on the
neurotherapeutics industry. NI Research has published NeuroInvestment since
1995; the Private CNS Company Review since 2003; and CNS
Disorders/Therapeutics since 2007. NI Research also provides licensing
consultation and research for large and small pharmaceutical firms. NI
Research has developed an unmatched information base regarding both
publicly and privately-held neuro-oriented companies.
To download PCNS 2010 information/order form:
http://www.niresearch.com/PCNS 2010 order.pdf
